Fluctuations in ovarian steroids during specific phases of the reproductive cycle, such as pre-menstruation, have been hypothesized to contribute to women's increased vulnerability to depression. This current study's goal is to summarize the literature regarding Premenstrual Dysphoric Disorder (PMDD) in the East Asian countries of Taiwan, China (including Hong Kong and Macau), Japan, and Korea.
Method:
A Pubmed and Chinese Electronic Periodical Service (CEPS) literature review was conducted using the key words “Premenstrual Dysphoric Disorder” along with “Japan,” “Korea,” “Taiwan,” “Hong Kong,” and “Macau.” Using these criteria, 17 articles were found. Three articles were excluded because they did not involve PMDD in the aforementioned countries. In addition to this search, an article found in a review of the research on reproductive mental health disorders in China was utilized. That review contained one article regarding PMDD with an English language abstract, which was utilized in this current article.
Results:
The rates of PMDD in East Asia (1.3–2.8%) appear to be lower than that seen in the Western literature (3–8%). Many of the risk factors for PMDD were the same in the Eastern and Western literature, although some key differences were found. The few studies on treatment of PMDD in East Asia have shown positive results.
Conclusions:
The rates of PMDD appear to be lower in East Asia, though reasons for this result are discussed. Few studies have been conducted examining the efficacy of psychotropic medications commonly used to treat PMDD in this population.
World Health Organization (WHO).Global Burden of Disease 2004 Update. Geneva, Switzerland: WHO Press, 2008.
2.
KesslerRCMcGonagleKASwartzMBlazerDGNelsonCB. Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity, and recurrence. Journal of Affective Disorders1993; 29: 85–96.
3.
KesslerRCMcGonagleKAZhaoSNelsonCBHughesMEshlemanS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry1994; 51: 18–19.
4.
JarvisCILynchAMMorinAK. Management strategies for premenstrual syndrome/ premenstrual dysphoric disorder. Annals of Pharmacotherapy2008; 42: 967–978.
5.
CohenLSSoaresCNOttoMWSweenyBHLibermanRFHarlowBL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older pre-menopausal women. The Harvard Study of Moods and Cycles. Journal of Affective Disorders2002; 70(2): 125–132.
6.
Rivera-TovarADFrankE. Late luteal phase dysphoric disorder in young women. American Journal of Psychiatry1990; 147(12): 1634–1636.
7.
BravermanPK. Premenstrual syndrome and premenstrual dysphoric disorder. Journal of Pediatric and Adolescent Gynecology2007; 20(1): 3–12.
8.
CunninghamJYonkersKAObrienSErikssonE. Update of research and treatment of premenstrual dysphoric disorder. Harvard Review of Psychiatry. 2009: 120–137.
9.
KlaininPArthurDG. Post-partum depression in Asian cultures: A review of the literature. International Journal of Nursing Studies2009; 46: 1355–1373.
10.
QiuJYXiaoZP. Reproductive-related depression in women: A review of two decades of research in China. Asia-Pacific Psychiatry2010; 2: 19–25.
11.
ShiSXZhangLZ. The investigation of premenstrual mental status in 302 women. Chinese Journal of Clinical Psychology1996; 6: 159–160. (in Chinese)
12.
TakedaTTasakaKSakataMMurataY. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Archives of Women's Mental Health2006; 9(4): 209–212.
13.
HsiaoMCLiuCYChenKCHsiehTT. Characteristics of women using a mental health clinic in a gynecologic out-patient setting. Psychiatry and Clinical Neuroscience2002; 56(4): 459–463.
14.
HsiaoMCLiuCYChenKCHsiehTT. Characteristics of women seeking treatment for premenstrual syndrome in Taiwan, Acta Psychiatrica Scandinavia2002; 106: 150–155.
15.
ChoiDLeeDYLehertPLeeISKimSHDennersteinL. The impact of premenstrual symptoms on activities of daily life in Korean women. Journal of Psychosomatic Obstetrics and Gynecology2010; 31(1): 10–15.
16.
HsiaoCCLiuCYHsiaoMC. No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder. Psychiatry and Clinical Neuroscience2004; 58(6): 593–599.
17.
HsuSCLiuCYHsiaoMC. A comparison of the Tridimensional Personality Questionnaire in premenstrual dysphoric disorder and major depressive disorder. Psychiatry and Clinical Neuroscience2007; 62(1): 109–114.
18.
InoueYTeraoTIwataNOkamotoKKolinaHOkamotoT. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: Findings from neuroendocrine challenge tests. Psychopharmacology2007; 190(2): 213–219.
19.
MatsumotoTUshiroyamaTKimuraTHayashiTMoritaniTl. Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder. Biopsychosocial Medicine2007; 20(1): 24.
20.
HsiaoMCLiuCT. Unusual manifestations of premenstrual syndrome. Psychiatry and Clinical Neuroscience2007; 61(1): 120–123.
21.
HsiaoMCLiuCY. Effective open-label treatment of premenstrual dysphoric disorder with venlafaxine. Psychiatry and Clinical Neuroscience2003; 57: 317–321.
22.
WuKYLiuCYHsiaoMC. Six-month paroxetine treatment of premenstrual dysphoric disorder: Continuous versus intermittent treatment protocols. Psychiatry and Clinical Neuroscience2008; 62(1): 109–114.
23.
YamadaKKanbaS. Effectiveness of kamishoyosan for premenstrual dysphoric disorder: Open-labeled pilot study. Psychiatry and Clinical Neuroscience2007; 61(3): 323–324.
24.
HuangKLTsaiSJ. St. John's Wort (Hypericum perforatum) as a treatment for premenstrual dysphoric disorder: Case report. International Journal of Psychiatry in Medicine2003; 33(3): 295–297.
25.
TaguchiRMatsubaraSYoshimotoSImaiKOhkuchiAKitakojiH. Acupuncture for premenstrual dysphoric disorder. Archives of Obstetrics and Gynecology2009; 280(6): 877–881.
26.
VigodSNFreyBNSoaresSNSteinerM. Approach to premenstrual dysphoria for the mental health practitioner. Psychiatric Clinics of North America2010; 33(2): 257–272.
27.
CheungFM. Facts and myths about somatization among the Chinese. In TsengWSYehEKLinTY, editors. Chinese societies and mental health. Hong Kong: Oxford University Press, 1995: 156–167.
28.
TelekTGondaXLazaryJBenkoAPapDVarghaA. The possible protective role of personality dimensions against PMS. Psychiatry Research2010; 179(1): 81–85.
29.
EppersonCNHagaKMasonGFSellersEGueorguievaRZhangW. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry2002; 59(9): 851–858.
30.
RadleyJJGosselinkKLSawchenkoPE. A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. Journal of Neuroscience2009; 29(22): 7330–7340.
31.
PuolakkaJMakarainenLViinikkaLYlikorkalaO. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. Journal of Reproductive Medicine1985; 30(3): 149–153.
32.
PriorJCVignaYSciarrettaDAlojadoNSchulzerM. Conditioning exercise decreases premenstrual symptoms: A prospective, controlled 6-month trial. Fertility and Sterility1987; 47(3): 402–408.
33.
Hernandez-ReifMMartinezAFieldTQuinteroOHartSBurmanI. Premenstrual symptoms are relieved by massage therapy. Journal of Psychosomatic Obstetrics and Gynecology2000; 82: 906–911.
34.
OlesonTFloccoW. Randomized controlled study of premenstrual symptoms treated with ear, hand, and foot reflexology. Obstetrics and Gynecology1993; 82: 906–911.
35.
Van ZakDB. Biofeedback treatments for premenstrual and premenstrual affective syndromes. International Journal of Psychosomatics1994; 41: 53–60.
36.
Thys-JacobsSStarkeyPBernsteinDTianJ. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. American Journal of Obstetrics and Gynecology1998; 179: 444–452.
37.
KashanianMMazinaniRJalalmaneshS. Pyridoxine (vitamin B6) therapy for premenstrual syndrome. International Journal of Obstetrics and Gynecology2007; 96: 43–44.
38.
AtmacaMKumruSTezcanE. Fluoxetine vs. Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Human Psychopharmacology2003; 18: 191–195.
39.
GoodaleILDomarADBensonH. Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstetrics and Gynecology1990; 75: 649–655.
